nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.209	1	CbGbCtD
Methotrexate—FOLR1—nephron—nephrolithiasis	0.031	0.132	CbGeAlD
Methotrexate—Dry cough—Hydrochlorothiazide—nephrolithiasis	0.0202	0.118	CcSEcCtD
Methotrexate—Obstructive airways disorder—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0803	CcSEcCtD
Methotrexate—SLCO3A1—nephron—nephrolithiasis	0.0128	0.0544	CbGeAlD
Methotrexate—SLC22A8—nephron—nephrolithiasis	0.00799	0.0339	CbGeAlD
Methotrexate—Raised liver function tests—Hydrochlorothiazide—nephrolithiasis	0.00677	0.0395	CcSEcCtD
Methotrexate—FOLR1—nephron tubule—nephrolithiasis	0.0067	0.0284	CbGeAlD
Methotrexate—SLC22A8—urine—nephrolithiasis	0.00641	0.0272	CbGeAlD
Methotrexate—FOLR1—renal system—nephrolithiasis	0.00609	0.0259	CbGeAlD
Methotrexate—FOLR1—kidney—nephrolithiasis	0.00589	0.025	CbGeAlD
Methotrexate—FOLR1—cortex of kidney—nephrolithiasis	0.00573	0.0243	CbGeAlD
Methotrexate—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.00487	0.0284	CcSEcCtD
Methotrexate—GGH—nephron tubule—nephrolithiasis	0.00445	0.0189	CbGeAlD
Methotrexate—GGH—renal system—nephrolithiasis	0.00405	0.0172	CbGeAlD
Methotrexate—SLCO4C1—nephron tubule—nephrolithiasis	0.00395	0.0168	CbGeAlD
Methotrexate—GGH—kidney—nephrolithiasis	0.00391	0.0166	CbGeAlD
Methotrexate—GGH—cortex of kidney—nephrolithiasis	0.00381	0.0162	CbGeAlD
Methotrexate—SLCO4C1—renal system—nephrolithiasis	0.00359	0.0152	CbGeAlD
Methotrexate—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00348	0.0203	CcSEcCtD
Methotrexate—SLCO4C1—kidney—nephrolithiasis	0.00347	0.0147	CbGeAlD
Methotrexate—ATIC—renal system—nephrolithiasis	0.00344	0.0146	CbGeAlD
Methotrexate—SLCO4C1—cortex of kidney—nephrolithiasis	0.00338	0.0143	CbGeAlD
Methotrexate—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00337	0.0197	CcSEcCtD
Methotrexate—FPGS—cortex of kidney—nephrolithiasis	0.00335	0.0142	CbGeAlD
Methotrexate—ATIC—kidney—nephrolithiasis	0.00333	0.0141	CbGeAlD
Methotrexate—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0032	0.0187	CcSEcCtD
Methotrexate—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00318	0.0186	CcSEcCtD
Methotrexate—SLC22A11—nephron tubule—nephrolithiasis	0.00306	0.013	CbGeAlD
Methotrexate—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00293	0.0171	CcSEcCtD
Methotrexate—SLC22A6—nephron tubule—nephrolithiasis	0.00288	0.0122	CbGeAlD
Methotrexate—SLCO1C1—renal system—nephrolithiasis	0.00286	0.0121	CbGeAlD
Methotrexate—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00282	0.0165	CcSEcCtD
Methotrexate—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00282	0.0165	CcSEcCtD
Methotrexate—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00278	0.0162	CcSEcCtD
Methotrexate—SLC22A11—renal system—nephrolithiasis	0.00278	0.0118	CbGeAlD
Methotrexate—SLCO1C1—kidney—nephrolithiasis	0.00277	0.0117	CbGeAlD
Methotrexate—SLC22A7—renal system—nephrolithiasis	0.00271	0.0115	CbGeAlD
Methotrexate—SLC22A11—kidney—nephrolithiasis	0.00269	0.0114	CbGeAlD
Methotrexate—SLC22A7—kidney—nephrolithiasis	0.00262	0.0111	CbGeAlD
Methotrexate—SLC22A11—cortex of kidney—nephrolithiasis	0.00262	0.0111	CbGeAlD
Methotrexate—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00261	0.0152	CcSEcCtD
Methotrexate—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00258	0.0151	CcSEcCtD
Methotrexate—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00258	0.0151	CcSEcCtD
Methotrexate—TYMS—nephron tubule—nephrolithiasis	0.00257	0.0109	CbGeAlD
Methotrexate—SLC22A7—cortex of kidney—nephrolithiasis	0.00255	0.0108	CbGeAlD
Methotrexate—DHFR—nephron tubule—nephrolithiasis	0.00254	0.0108	CbGeAlD
Methotrexate—SLCO3A1—renal system—nephrolithiasis	0.00252	0.0107	CbGeAlD
Methotrexate—SLC22A6—cortex of kidney—nephrolithiasis	0.00247	0.0105	CbGeAlD
Methotrexate—PGD—nephron tubule—nephrolithiasis	0.00244	0.0104	CbGeAlD
Methotrexate—SLCO3A1—kidney—nephrolithiasis	0.00243	0.0103	CbGeAlD
Methotrexate—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0024	0.014	CcSEcCtD
Methotrexate—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00239	0.014	CcSEcCtD
Methotrexate—SLCO3A1—cortex of kidney—nephrolithiasis	0.00237	0.0101	CbGeAlD
Methotrexate—DHFR—renal system—nephrolithiasis	0.00231	0.00981	CbGeAlD
Methotrexate—DHFR—kidney—nephrolithiasis	0.00223	0.00948	CbGeAlD
Methotrexate—PGD—renal system—nephrolithiasis	0.00222	0.00943	CbGeAlD
Methotrexate—TYMS—cortex of kidney—nephrolithiasis	0.0022	0.00933	CbGeAlD
Methotrexate—DHFR—cortex of kidney—nephrolithiasis	0.00218	0.00924	CbGeAlD
Methotrexate—AOX1—nephron tubule—nephrolithiasis	0.00215	0.00914	CbGeAlD
Methotrexate—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00215	0.0125	CcSEcCtD
Methotrexate—PGD—kidney—nephrolithiasis	0.00215	0.00912	CbGeAlD
Methotrexate—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00213	0.0124	CcSEcCtD
Methotrexate—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00209	0.0122	CcSEcCtD
Methotrexate—PGD—cortex of kidney—nephrolithiasis	0.00209	0.00888	CbGeAlD
Methotrexate—SLC16A1—renal system—nephrolithiasis	0.00207	0.00881	CbGeAlD
Methotrexate—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00205	0.012	CcSEcCtD
Methotrexate—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00204	0.0119	CcSEcCtD
Methotrexate—SLCO1B1—renal system—nephrolithiasis	0.00202	0.00857	CbGeAlD
Methotrexate—SLC16A1—kidney—nephrolithiasis	0.002	0.00851	CbGeAlD
Methotrexate—AOX1—renal system—nephrolithiasis	0.00196	0.00831	CbGeAlD
Methotrexate—SLCO1B1—kidney—nephrolithiasis	0.00195	0.00828	CbGeAlD
Methotrexate—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00192	0.0112	CcSEcCtD
Methotrexate—ABCC3—renal system—nephrolithiasis	0.00191	0.00813	CbGeAlD
Methotrexate—ABCC10—renal system—nephrolithiasis	0.0019	0.00809	CbGeAlD
Methotrexate—AOX1—kidney—nephrolithiasis	0.00189	0.00803	CbGeAlD
Methotrexate—ABCC3—kidney—nephrolithiasis	0.00185	0.00786	CbGeAlD
Methotrexate—AOX1—cortex of kidney—nephrolithiasis	0.00184	0.00782	CbGeAlD
Methotrexate—ABCC10—kidney—nephrolithiasis	0.00184	0.00782	CbGeAlD
Methotrexate—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00183	0.0107	CcSEcCtD
Methotrexate—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00183	0.0107	CcSEcCtD
Methotrexate—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00182	0.0106	CcSEcCtD
Methotrexate—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0018	0.0105	CcSEcCtD
Methotrexate—ABCC10—cortex of kidney—nephrolithiasis	0.00179	0.00761	CbGeAlD
Methotrexate—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00179	0.0104	CcSEcCtD
Methotrexate—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00176	0.0103	CcSEcCtD
Methotrexate—ABCC4—nephron tubule—nephrolithiasis	0.00174	0.00738	CbGeAlD
Methotrexate—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00173	0.0101	CcSEcCtD
Methotrexate—SLC22A8—nephron tubule—nephrolithiasis	0.00172	0.00732	CbGeAlD
Methotrexate—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00172	0.01	CcSEcCtD
Methotrexate—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.0017	0.00992	CcSEcCtD
Methotrexate—ABCC2—nephron tubule—nephrolithiasis	0.00168	0.00714	CbGeAlD
Methotrexate—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00168	0.00978	CcSEcCtD
Methotrexate—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00167	0.00973	CcSEcCtD
Methotrexate—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00165	0.00962	CcSEcCtD
Methotrexate—SLCO1A2—renal system—nephrolithiasis	0.00164	0.00697	CbGeAlD
Methotrexate—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00163	0.00952	CcSEcCtD
Methotrexate—SLCO1A2—kidney—nephrolithiasis	0.00159	0.00674	CbGeAlD
Methotrexate—ABCC4—renal system—nephrolithiasis	0.00158	0.00671	CbGeAlD
Methotrexate—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00157	0.00916	CcSEcCtD
Methotrexate—SLC22A8—renal system—nephrolithiasis	0.00157	0.00666	CbGeAlD
Methotrexate—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00909	CcSEcCtD
Methotrexate—ABCC2—renal system—nephrolithiasis	0.00153	0.00649	CbGeAlD
Methotrexate—ABCC4—kidney—nephrolithiasis	0.00153	0.00649	CbGeAlD
Methotrexate—SLC22A8—kidney—nephrolithiasis	0.00152	0.00643	CbGeAlD
Methotrexate—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00151	0.00882	CcSEcCtD
Methotrexate—ABCC4—cortex of kidney—nephrolithiasis	0.00149	0.00632	CbGeAlD
Methotrexate—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00148	0.00866	CcSEcCtD
Methotrexate—ABCC2—kidney—nephrolithiasis	0.00148	0.00628	CbGeAlD
Methotrexate—SLC22A8—cortex of kidney—nephrolithiasis	0.00148	0.00627	CbGeAlD
Methotrexate—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00146	0.00854	CcSEcCtD
Methotrexate—ABCC2—cortex of kidney—nephrolithiasis	0.00144	0.00611	CbGeAlD
Methotrexate—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00139	0.00809	CcSEcCtD
Methotrexate—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00137	0.00797	CcSEcCtD
Methotrexate—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00134	0.00781	CcSEcCtD
Methotrexate—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00132	0.00771	CcSEcCtD
Methotrexate—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00129	0.00751	CcSEcCtD
Methotrexate—ABCC1—cortex of kidney—nephrolithiasis	0.00127	0.00539	CbGeAlD
Methotrexate—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00127	0.0074	CcSEcCtD
Methotrexate—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00126	0.00737	CcSEcCtD
Methotrexate—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00123	0.00719	CcSEcCtD
Methotrexate—ABCG2—nephron tubule—nephrolithiasis	0.00123	0.00521	CbGeAlD
Methotrexate—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00123	0.00716	CcSEcCtD
Methotrexate—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00122	0.00714	CcSEcCtD
Methotrexate—Cough—Hydrochlorothiazide—nephrolithiasis	0.00119	0.00696	CcSEcCtD
Methotrexate—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00116	0.00679	CcSEcCtD
Methotrexate—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00116	0.00679	CcSEcCtD
Methotrexate—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00116	0.00679	CcSEcCtD
Methotrexate—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00115	0.00671	CcSEcCtD
Methotrexate—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00112	0.00656	CcSEcCtD
Methotrexate—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00111	0.00651	CcSEcCtD
Methotrexate—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00109	0.00637	CcSEcCtD
Methotrexate—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00629	CcSEcCtD
Methotrexate—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00106	0.0062	CcSEcCtD
Methotrexate—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00104	0.00608	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00102	0.00593	CcSEcCtD
Methotrexate—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00101	0.00588	CcSEcCtD
Methotrexate—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.001	0.00584	CcSEcCtD
Methotrexate—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000994	0.0058	CcSEcCtD
Methotrexate—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000991	0.00578	CcSEcCtD
Methotrexate—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000981	0.00573	CcSEcCtD
Methotrexate—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000969	0.00566	CcSEcCtD
Methotrexate—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000961	0.00561	CcSEcCtD
Methotrexate—Pain—Hydrochlorothiazide—nephrolithiasis	0.000953	0.00556	CcSEcCtD
Methotrexate—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000918	0.00536	CcSEcCtD
Methotrexate—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000911	0.00532	CcSEcCtD
Methotrexate—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000885	0.00517	CcSEcCtD
Methotrexate—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000881	0.00514	CcSEcCtD
Methotrexate—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000881	0.00514	CcSEcCtD
Methotrexate—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000821	0.00479	CcSEcCtD
Methotrexate—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0008	0.00467	CcSEcCtD
Methotrexate—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000788	0.0046	CcSEcCtD
Methotrexate—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000762	0.00445	CcSEcCtD
Methotrexate—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000737	0.0043	CcSEcCtD
Methotrexate—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000709	0.00414	CcSEcCtD
Methotrexate—Rash—Hydrochlorothiazide—nephrolithiasis	0.000703	0.0041	CcSEcCtD
Methotrexate—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000702	0.0041	CcSEcCtD
Methotrexate—Headache—Hydrochlorothiazide—nephrolithiasis	0.000698	0.00408	CcSEcCtD
Methotrexate—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000662	0.00386	CcSEcCtD
Methotrexate—ABCB1—nephron tubule—nephrolithiasis	0.000605	0.00257	CbGeAlD
Methotrexate—ABCB1—renal system—nephrolithiasis	0.00055	0.00234	CbGeAlD
Methotrexate—ABCB1—kidney—nephrolithiasis	0.000532	0.00226	CbGeAlD
Methotrexate—ABCB1—cortex of kidney—nephrolithiasis	0.000518	0.0022	CbGeAlD
Methotrexate—SLC19A1—Metabolism—AQP1—nephrolithiasis	0.000378	0.000985	CbGpPWpGaD
Methotrexate—PGD—Metabolism—AGXT—nephrolithiasis	0.000378	0.000985	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000378	0.000984	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—SLC7A9—nephrolithiasis	0.000378	0.000983	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—DGKH—nephrolithiasis	0.000378	0.000983	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000377	0.000982	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000377	0.000982	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—ATP6V0A4—nephrolithiasis	0.000374	0.000975	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000374	0.000974	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000374	0.000974	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000369	0.000962	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000367	0.000955	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000367	0.000955	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000365	0.000951	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000365	0.000951	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000359	0.000936	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000359	0.000936	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000358	0.000932	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000354	0.000921	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—SLC26A1—nephrolithiasis	0.000352	0.000916	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—APRT—nephrolithiasis	0.000352	0.000916	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000349	0.000909	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000349	0.000909	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000347	0.000903	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000347	0.000903	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000346	0.0009	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000346	0.0009	CbGpPWpGaD
Methotrexate—PGD—Disease—ATP6V0A4—nephrolithiasis	0.000342	0.000892	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—CHRM3—nephrolithiasis	0.000342	0.000891	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000339	0.000884	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000339	0.000884	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000338	0.00088	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000338	0.00088	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000336	0.000875	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000333	0.000868	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000333	0.000868	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000327	0.000852	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000327	0.000852	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000327	0.000851	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000327	0.000851	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000323	0.000842	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000323	0.000842	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000322	0.000839	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000322	0.000839	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—AQP1—nephrolithiasis	0.000322	0.000838	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—AQP1—nephrolithiasis	0.000322	0.000838	CbGpPWpGaD
Methotrexate—PGD—Metabolism—SLC26A1—nephrolithiasis	0.000322	0.000838	CbGpPWpGaD
Methotrexate—PGD—Metabolism—APRT—nephrolithiasis	0.000322	0.000838	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000313	0.000815	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000313	0.000815	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000311	0.00081	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000307	0.000801	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000307	0.000801	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000307	0.000799	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000307	0.000799	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000302	0.000788	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000302	0.000788	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000294	0.000766	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000294	0.000766	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—CHRM3—nephrolithiasis	0.000291	0.000758	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—CHRM3—nephrolithiasis	0.000291	0.000758	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000291	0.000757	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000291	0.000757	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000287	0.000748	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000287	0.000748	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000285	0.000743	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000285	0.000743	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000285	0.000741	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000285	0.000741	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—SLC7A9—nephrolithiasis	0.000282	0.000733	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—DGKH—nephrolithiasis	0.000282	0.000733	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GRHPR—nephrolithiasis	0.00028	0.000729	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GRHPR—nephrolithiasis	0.000274	0.000712	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000273	0.000712	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000273	0.000712	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000272	0.000709	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000272	0.000709	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000267	0.000694	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000262	0.000682	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000262	0.000682	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000261	0.000681	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000259	0.000675	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000259	0.000675	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000256	0.000667	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000256	0.000667	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000254	0.000662	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000254	0.000662	CbGpPWpGaD
Methotrexate—MTHFR—Disease—SLC26A1—nephrolithiasis	0.000253	0.00066	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000253	0.00066	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000253	0.00066	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—AQP1—nephrolithiasis	0.000251	0.000653	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—AGXT—nephrolithiasis	0.00025	0.00065	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GRHPR—nephrolithiasis	0.000249	0.000648	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000248	0.000646	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000248	0.000646	CbGpPWpGaD
Methotrexate—AOX1—Disease—SLC26A1—nephrolithiasis	0.000248	0.000645	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000247	0.000644	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000245	0.000638	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000245	0.000638	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—AGXT—nephrolithiasis	0.000244	0.000635	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000244	0.000635	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000244	0.000635	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000244	0.000634	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000244	0.000634	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000242	0.00063	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000238	0.00062	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000238	0.00062	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000233	0.000607	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000233	0.000607	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000231	0.000601	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000231	0.000601	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00023	0.000598	CbGpPWpGaD
Methotrexate—PGD—Metabolism—AQP1—nephrolithiasis	0.000229	0.000597	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000228	0.000593	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000228	0.000593	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GRHPR—nephrolithiasis	0.000227	0.00059	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—CHRM3—nephrolithiasis	0.000227	0.00059	CbGpPWpGaD
Methotrexate—MTHFR—Disease—ATP6V0A4—nephrolithiasis	0.000226	0.000588	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000226	0.000588	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000226	0.000588	CbGpPWpGaD
Methotrexate—DHFR—Disease—SLC26A1—nephrolithiasis	0.000225	0.000586	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—AGXT—nephrolithiasis	0.000222	0.000578	CbGpPWpGaD
Methotrexate—AOX1—Disease—ATP6V0A4—nephrolithiasis	0.000221	0.000575	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GRHPR—nephrolithiasis	0.000217	0.000566	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000217	0.000565	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000217	0.000564	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000217	0.000564	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000216	0.000562	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000216	0.000562	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000215	0.000561	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000215	0.000561	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—APRT—nephrolithiasis	0.000212	0.000553	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—SLC26A1—nephrolithiasis	0.000212	0.000553	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000212	0.000553	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000212	0.000553	CbGpPWpGaD
Methotrexate—PGD—Metabolism—CHRM3—nephrolithiasis	0.000207	0.00054	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—SLC26A1—nephrolithiasis	0.000207	0.00054	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—APRT—nephrolithiasis	0.000207	0.00054	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000207	0.00054	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000206	0.000535	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000206	0.000535	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000203	0.000529	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000203	0.000529	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000203	0.000529	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—AGXT—nephrolithiasis	0.000202	0.000526	CbGpPWpGaD
Methotrexate—DHFR—Disease—ATP6V0A4—nephrolithiasis	0.000201	0.000523	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000201	0.000522	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000201	0.000522	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GRHPR—nephrolithiasis	0.000199	0.000519	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000195	0.000507	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—AGXT—nephrolithiasis	0.000194	0.000504	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000193	0.000503	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000193	0.000503	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000192	0.0005	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000189	0.000492	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000189	0.000492	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—APRT—nephrolithiasis	0.000189	0.000491	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—SLC26A1—nephrolithiasis	0.000189	0.000491	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00018	0.00047	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GRHPR—nephrolithiasis	0.00018	0.000468	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000179	0.000465	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000179	0.000465	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—AGXT—nephrolithiasis	0.000178	0.000462	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000176	0.000457	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000176	0.000457	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—APRT—nephrolithiasis	0.000172	0.000447	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—SLC26A1—nephrolithiasis	0.000172	0.000447	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00017	0.000442	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000168	0.000438	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—APRT—nephrolithiasis	0.000165	0.000429	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—SLC26A1—nephrolithiasis	0.000165	0.000429	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000164	0.000428	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000162	0.000423	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—AGXT—nephrolithiasis	0.00016	0.000417	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GRHPR—nephrolithiasis	0.000157	0.000408	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000154	0.000402	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000154	0.000401	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000154	0.000401	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—AQP1—nephrolithiasis	0.000151	0.000394	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—SLC26A1—nephrolithiasis	0.000151	0.000393	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—APRT—nephrolithiasis	0.000151	0.000393	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—AQP1—nephrolithiasis	0.000148	0.000385	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000143	0.000372	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GRHPR—nephrolithiasis	0.000141	0.000367	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—AGXT—nephrolithiasis	0.00014	0.000363	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—CHRM3—nephrolithiasis	0.000137	0.000356	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—APRT—nephrolithiasis	0.000136	0.000355	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—SLC26A1—nephrolithiasis	0.000136	0.000355	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—AQP1—nephrolithiasis	0.000134	0.00035	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GRHPR—nephrolithiasis	0.000134	0.000349	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—CHRM3—nephrolithiasis	0.000134	0.000348	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000133	0.000347	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000133	0.000347	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SLC26A1—nephrolithiasis	0.000127	0.000332	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.000127	0.000332	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—DGKH—nephrolithiasis	0.000127	0.000332	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—AGXT—nephrolithiasis	0.000126	0.000327	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.000124	0.000323	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000124	0.000322	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000124	0.000322	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—AQP1—nephrolithiasis	0.000122	0.000319	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CHRM3—nephrolithiasis	0.000122	0.000317	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—AGXT—nephrolithiasis	0.000119	0.000311	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—SLC26A1—nephrolithiasis	0.000119	0.000309	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—APRT—nephrolithiasis	0.000119	0.000309	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—AQP1—nephrolithiasis	0.000117	0.000305	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000117	0.000304	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000117	0.000304	CbGpPWpGaD
Methotrexate—ABCC1—Disease—ATP6V0A4—nephrolithiasis	0.000114	0.000296	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CHRM3—nephrolithiasis	0.000111	0.000288	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—AGXT—nephrolithiasis	0.00011	0.000288	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00011	0.000287	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00011	0.000287	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000108	0.000282	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000108	0.000282	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—AQP1—nephrolithiasis	0.000108	0.00028	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SLC26A1—nephrolithiasis	0.000107	0.000278	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APRT—nephrolithiasis	0.000107	0.000278	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CHRM3—nephrolithiasis	0.000106	0.000276	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SLC26A1—nephrolithiasis	0.000101	0.000264	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APRT—nephrolithiasis	0.000101	0.000264	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CHRM3—nephrolithiasis	9.73e-05	0.000253	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—AQP1—nephrolithiasis	9.71e-05	0.000253	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	9.66e-05	0.000252	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	9.66e-05	0.000252	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SLC26A1—nephrolithiasis	9.39e-05	0.000245	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APRT—nephrolithiasis	9.39e-05	0.000245	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	8.82e-05	0.00023	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CHRM3—nephrolithiasis	8.78e-05	0.000229	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—AQP1—nephrolithiasis	8.45e-05	0.00022	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	7.73e-05	0.000201	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GRHPR—nephrolithiasis	7.65e-05	0.000199	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CHRM3—nephrolithiasis	7.64e-05	0.000199	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—AQP1—nephrolithiasis	7.61e-05	0.000198	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—AQP1—nephrolithiasis	7.23e-05	0.000188	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CHRM3—nephrolithiasis	6.88e-05	0.000179	CbGpPWpGaD
Methotrexate—ALB—Metabolism—AGXT—nephrolithiasis	6.82e-05	0.000178	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GRHPR—nephrolithiasis	6.7e-05	0.000174	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—AQP1—nephrolithiasis	6.69e-05	0.000174	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CHRM3—nephrolithiasis	6.54e-05	0.00017	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CHRM3—nephrolithiasis	6.05e-05	0.000158	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—AGXT—nephrolithiasis	5.97e-05	0.000156	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APRT—nephrolithiasis	5.8e-05	0.000151	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SLC26A1—nephrolithiasis	5.8e-05	0.000151	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SLC26A1—nephrolithiasis	5.08e-05	0.000132	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APRT—nephrolithiasis	5.08e-05	0.000132	CbGpPWpGaD
Methotrexate—ALB—Metabolism—AQP1—nephrolithiasis	4.13e-05	0.000108	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CHRM3—nephrolithiasis	3.73e-05	9.73e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—AQP1—nephrolithiasis	3.62e-05	9.42e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CHRM3—nephrolithiasis	3.27e-05	8.52e-05	CbGpPWpGaD
